Q1 2024 Holdings
Filed 2024-05-15 | 51 holdings | $335.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Laboratory Corporation of America Holdings | COM NEW | 50540R409 | $49.4M | 225,902 | 14.7% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $37.0M | 1,362,700 | 11.0% |
| Cigna Group(CI) | COM | 125523100 | $27.6M | 76,086 | 8.2% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $21.1M | 393,420 | 6.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $13.6M | 51,000 | 4.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $11.3M | 263,445 | 3.4% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $9.8M | 74,179 | 2.9% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $9.2M | 105,000 | 2.7% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $9.0M | 479,023 | 2.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $8.8M | 535,741 | 2.6% |
| Ironwood Pharmaceuticals Inc(IRWD)Put | COM CL A | 46333X108 | $8.5M | 970,800 | 2.5% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $7.8M | 585,418 | 2.3% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $7.7M | 33,878 | 2.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $6.3M | 635,969 | 1.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.3M | 203,174 | 1.9% |
| Humacyte Inc(HUMA) | COM | 44486Q103 | $6.2M | 2,000,000 | 1.9% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $6.0M | 87,354 | 1.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $5.8M | 410,267 | 1.7% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $5.5M | 536,163 | 1.6% |
| Healthcare Services Group Inc(HCSG) | COM | 421906108 | $5.3M | 421,317 | 1.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $5.2M | 78,000 | 1.5% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $5.2M | 243,035 | 1.5% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.0M | 2,427,184 | 1.5% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $5.0M | 3,588,427 | 1.5% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $4.9M | 1,336,231 | 1.4% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $4.9M | 273,720 | 1.4% |
| Integra Lifesciences Holdings Corp(IART) | COM NEW | 457985208 | $4.9M | 137,000 | 1.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.5M | 383,026 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.5M | 1,598,590 | 1.0% |
| Pacira Biosciences Inc(PCRX)Put | COM | 695127100 | $3.3M | 112,000 | 1.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.1M | 177,004 | 0.9% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.0M | 225,496 | 0.9% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $2.8M | 1,539,352 | 0.8% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $2.8M | 315,000 | 0.8% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $2.3M | 468,871 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $2.1M | 378,000 | 0.6% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $2.0M | 143,000 | 0.6% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $1.9M | 276,603 | 0.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $1.5M | 163,363 | 0.5% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $1.5M | 320,394 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.4M | 33,007 | 0.4% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $1.3M | 149,400 | 0.4% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $816.4K | 121,672 | 0.2% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $685.8K | 50,839 | 0.2% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $516.4K | 102,049 | 0.2% |
| Nextcure Inc | COM | 65343E108 | $289.9K | 130,000 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $220.8K | 10,151 | 0.1% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $156.4K | 254,150 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $109.9K | 400,000 | 0.0% |
| Humacyte Inc | *W EXP 08/27/202 | 44486Q111 | $31.0K | 49,998 | 0.0% |